Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

SELL
$1.63 - $3.08 $68,975 - $130,333
-42,316 Reduced 70.41%
17,781 $34,000
Q4 2023

Feb 26, 2024

BUY
$1.07 - $3.07 $64,303 - $184,497
60,097 New
60,097 $163,000
Q4 2022

Feb 15, 2023

BUY
$1.99 - $3.52 $111,479 - $197,190
56,020 New
56,020 $132,000
Q2 2022

Aug 09, 2022

BUY
$2.58 - $4.99 $4,602 - $8,902
1,784 Added 15.05%
13,638 $61,000
Q1 2022

May 17, 2022

SELL
$3.93 - $7.7 $120,639 - $236,366
-30,697 Reduced 72.14%
11,854 $47,000
Q4 2021

Feb 17, 2022

BUY
$7.1 - $12.82 $302,112 - $545,503
42,551 New
42,551 $302,000
Q4 2020

Feb 24, 2021

SELL
$11.05 - $16.62 $195,684 - $294,323
-17,709 Closed
0 $0
Q3 2020

Dec 11, 2020

SELL
$11.69 - $14.54 $301,473 - $374,972
-25,789 Reduced 59.29%
17,709 $226,000
Q2 2020

Aug 07, 2020

BUY
$9.75 - $17.6 $424,105 - $765,564
43,498 New
43,498 $649,000
Q4 2019

Feb 04, 2020

SELL
$6.71 - $9.55 $228,301 - $324,929
-34,024 Closed
0 $0
Q3 2019

Nov 20, 2019

BUY
$6.0 - $9.6 $204,144 - $326,630
34,024 New
34,024 $304,000
Q4 2018

Jan 16, 2019

SELL
$2.65 - $4.26 $108,321 - $174,131
-40,876 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$0.83 - $4.16 $33,927 - $170,044
40,876 New
40,876 $166,000
Q1 2018

May 14, 2018

SELL
$1.38 - $2.33 $44,424 - $75,007
-32,192 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$1.63 - $2.0 $18,358 - $22,526
11,263 Added 53.82%
32,192 $61,000
Q3 2017

Nov 15, 2017

BUY
$1.59 - $3.0 $33,277 - $62,787
20,929
20,929 $0

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $47.3M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.